GH Research PLC Announces Pricing of Initial Public Offering

info@newsaktuell.ch (presseportal.ch) — Fri, 25 Jun 2021 02:44:09 +0200

GH Research Ltd [Newsroom]
Dublin (ots/PRNewswire) - GH Research PLC, a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today announced the pricing of its initial public offering in the United States ... Lesen Sie hier weiter...

GH Research Ltd. Announces Completion of Phase 1 Clinical Study with GH001 (5-Methoxy-N,N-Dimethyltryptamine) in Healthy Volunteers and Updates on Further Progress

info@newsaktuell.ch (presseportal.ch) — Fri, 20 Nov 2020 15:11:16 +0100

GH Research Ltd [Newsroom]
Dublin (ots/PRNewswire) - GH Research Limited ("GH Research" or "the Company") today announced the successful completion of a Phase 1 clinical study with GH001 in healthy volunteers. The Company is currently recruiting for a Phase 1/2 clinical study ... Lesen Sie hier weiter...

Presseportal.ch - GH Research Ltd

GH Research PLC Announces Pricing of Initial Public Offering

GH Research Ltd. Announces Completion of Phase 1 Clinical Study with GH001 (5-Methoxy-N,N-Dimethyltryptamine) in Healthy Volunteers and Updates on Further Progress